Look for:

Products

CHARLES RIVER LABS INTL INC.


ISIN:
US1598641074
WKN:
159864107

2024/06/21 22:00:02
Price
211.60 USD
Difference 0.94% (1.97)

General attributes

ISINUS1598641074
SymbolCRL
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)10,181 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)211.66 USD (100)
Ask (Ask size)218.97 USD (100)
Open210.33 USD
High212.30 USD
Low208.6943 USD
Close (prev. day)209.63 USD
VWAP211.416848 USD
Volume (pcs)681,775
Trading volume144,106,643.23
Number of trades11,731
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: CHARLES RIVER LABS INTL INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/06/21 22:00:02
Price
211.60 USD
Difference 0.94% (1.97)

General attributes

ISINUS1598641074
SymbolCRL
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)10,181 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)211.66 USD (100)
Ask (Ask size)218.97 USD (100)
Open210.33 USD
High212.30 USD
Low208.6943 USD
Close (prev. day)209.63 USD
VWAP211.416848 USD
Volume (pcs)681,775
Trading volume144,106,643.23
Number of trades11,731
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-10.23%+2.56%-41.32%
Perf (abs.)-24.12+5.29-148.99
Beta1.641.411.21
Volatility31.4731.6837.74
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)209.78 USD (459,999)
Ø price 30 days | Ø volume 30 days (pcs.)217.05 USD (565,465)
Ø price 100 days | Ø volume 100 days (pcs.)236.91 USD (540,384)
Ø price 250 days | Ø volume 250 days (pcs.)216.66 USD (513,492)
YTD High | date275.00 USD (2024/03/08)
YTD Low | date201.01 USD (2024/01/17)
52 Weeks High | date275.00 USD (2024/03/08)
52 Weeks Low | date161.65 USD (2023/11/01)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/06/2122:26197.90 EUR0.001
Stuttgart2024/06/2121:53197.75 EUR0.007
NYSE2024/06/2122:00211.60 USD144.1111,731
Munich2024/06/2108:04195.30 EUR0.001
Frankfurt2024/06/2109:09195.05 EUR0.002
Duesseldorf2024/06/2108:11194.90 EUR0.003
Berlin2024/06/2120:21196.85 EUR0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=142312&ID_TYPE_IMAGE_LOGO=2

Contact Details

CHARLES RIVER LABORATORIES INTERNATIONAL INC.
- -
251 Ballardvale Street - 01887 Wilmington
Telefon: +1-781-222-6000
Fax: +
E-mail: askcharlesriver@crl.com

PDF Downloads

Company report: CHARLES RIVER LABS INTL INC.PDF Download

Company Profile

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Members of Management Board

Craig ThompsonMember of Board of Directors
Deborah KochevarMember of Board of Directors
Martin MacKayMember of Board of Directors
Nancy AndrewsMember of Board of Directors
George LladoMember of Board of Directors
George MassaroMember of Board of Directors
Reshema Kemps-PolancoMember of Board of Directors
Richard WallmanMember of Board of Directors
Robert BertoliniMember of Board of Directors
Virginia WilsonMember of Board of Directors
James FosterChairman of Managing Board
Birgit GirshickMember of Executive Committee
Flavia PeaseMember of Executive Committee
Gina M. MullaneMember of Executive Committee
John C. HoMember of Executive Committee
Julie FrearsonMember of Executive Committee
Kristen M. EisenhauerMember of Executive Committee
Mark MintzMember of Executive Committee
Matthew L. DanielMember of Executive Committee
Michael G. KnellMember of Executive Committee
Victoria L. CreamerMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.